Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-17-008861
Filing Date
2017-02-14
Accepted
2017-02-14 07:56:41
Documents
2
Period of Report
2017-02-14

Document Format Files

Seq Description Document Type Size
1 6-K a17-4066_36k.htm 6-K 20808
2 EX-12.3 a17-4066_3ex12d3.htm EX-12.3 67864
  Complete submission text file 0001104659-17-008861.txt   89622
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 17602488
SIC: 2834 Pharmaceutical Preparations